The Effect of Food on the Pharmacokinetics of Paclitaxel Administered Orally as Oraxol

Summary

This is multicenter, open-label, 2-part crossover study. Eligible subjects will have metastatic or unresectable solid tumors. This study includes a pretreatment and treatment phase. The pretreatment phase consists of screening and baseline. The treatment phase consists of Periods 1 and 2 (Part A), Treatment (Part B), and Follow-up.

Timeline

Start

2019-08-05

Primary completion

2023-05-12

Completion

2023-05-12

Outcome

Outcome not reported

Stopped (Business): “STUDY HALTED DUE TO FINANCIAL CONTRAINTS”

Drugs

Indications